Nightstar Therapeutics (Nasdaq: NITE) to Ring The

ADVISORY, Sept. 28, 2017 (GLOBE NEWSWIRE) --

What:  Nightstar Therapeutics plc (Nasdaq: NITE ), a leading clinical-stage gene therapy company focused on novel one-time treatments for patients suffering from rare inherited retinal diseases that would otherwise progress to blindness, will visit the Nasdaq MarketSite in Times Square in celebration of its initial public offering (IPO).

In honor of the occasion, David Fellows, Chief Executive Officer and Board Member , will ring the Closing Bell. 

Where: Nasdaq MarketSite – 4 Times Square – 43 ^rd & Broadway – Broadcast Studio

When: Thursday, September 28, 2017 – 3:45 p.m. to 4:00 p.m. ET        

Nightstar Therapeutics plc Contact: Alicia Davis, THRUST IR 910-620-3302 alicia@thrustir.com

Nasdaq MarketSite Media Contact: Emily Pan (646) 441-5120 emily.pan@nasdaq.com

Feed Information: Fiber Line (Encompass Waterfront): 4463

Gal 3C/06C 95.05 degrees West 18 mhz Lower DL 3811 Vertical FEC 3/4 SR 13.235 DR 18.295411 MOD 4:2:0 DVBS QPSK

Social Media: For multimedia features such as exclusive content, photo postings, status updates and video of bell ceremonies, please visit our Facebook page: http://www.facebook.com/NASDAQ .

For photos from ceremonies and events, please visit our Instagram page: http://instagram.com/nasdaq

For livestream of ceremonies and events, please visit our YouTube page: http://www.youtube.com/nasdaq/live

For news tweets, please visit our Twitter page: http://twitter.com/nasdaq

For exciting viral content and ceremony photos, please visit our Tumblr page: http://nasdaq.tumblr.com/

Webcast: A live stream of the Nasdaq Closing Bell will be available at: https://new.livestream.com/nasdaq/live or http://www.nasdaq.com/about/marketsitetowervideo.asx

Photos: To obtain a hi-resolution photograph of the Market Close, please go to http://business.nasdaq.com/discover/market-bell-ceremonies and click on the market close of your choice.

About Nightstar Therapeutics Limited Nightstar is a leading clinical-stage gene therapy company focused on developing and commercializing novel one-time treatments for patients suffering from rare inherited retinal diseases that would otherwise progress to blindness.

About Nasdaq: Nasdaq (Nasdaq: NDAQ ) is a leading global provider of trading, clearing, exchange technology, listing, information and public company services. Through its diverse portfolio of solutions, Nasdaq enables customers to plan, optimize and execute their business vision with confidence, using proven technologies that provide transparency and insight for navigating today's global capital markets. As the creator of the world's first electronic stock market, its technology powers more than 90 marketplaces in 50 countries, and 1 in 10 of the world's securities transactions. Nasdaq is home to approximately 3,900 total listings with a market value of approximately $12 trillion. To learn more, visit: http://business.nasdaq.com   

-NDAQA-